Elaine C Johnson1, William O Cepurna1, Dongseok Choi2, Tiffany E Choe1, John C Morrison1. 1. The Kenneth C. Swan Ocular Neurobiology Laboratory, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States. 2. The Kenneth C. Swan Ocular Neurobiology Laboratory, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States Public Health & Preventive Medicine, Oregon Health & Science University, Portland, Oregon, United States.
Abstract
PURPOSE: Optic nerve injury has been found to be dramatically reduced in a genetic mouse glaucoma model following exposure to sublethal, head-only irradiation. In this study, the same radiation treatment was used prior to experimental induction of elevated intraocular pressure (IOP) to determine if radiation is neuroprotective in another glaucoma model. METHODS: Episcleral vein injection of hypertonic saline was used to elevate IOP unilaterally in two groups of rats: (1) otherwise untreated and (2) radiation pretreated, n > 25/group. Intraocular pressure histories were collected for 5 weeks, when optic nerves were prepared and graded for injury. Statistical analyses were used to compare IOP history and nerve injury. The density of microglia and macrophages in two nerve head regions was determined by Iba1 immunolabeling. RESULTS: Mean and peak IOP elevations were not different between the two glaucoma model groups. Mean optic nerve injury grades were not different in glaucoma model optic nerves and were equivalent to approximately 35% of axons degenerating. Nerves selected for lower mean or peak IOP elevations did not differ in optic nerve injury. Similarly, nerves selected for lower injury grade did not differ in IOP exposure. By multiple regression modeling, nerve injury grade was most significantly associated with mean IOP (P < 0.002). There was no significant effect of radiation treatment. Iba1+ cell density was not altered by radiation treatment. CONCLUSIONS: In contrast to previous observations in a mouse genetic glaucoma model, head-only irradiation offers the adult rat optic nerve no protection from optic nerve degeneration due to chronic, experimentally induced IOP elevation. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE:Optic nerve injury has been found to be dramatically reduced in a genetic mouseglaucoma model following exposure to sublethal, head-only irradiation. In this study, the same radiation treatment was used prior to experimental induction of elevated intraocular pressure (IOP) to determine if radiation is neuroprotective in another glaucoma model. METHODS: Episcleral vein injection of hypertonic saline was used to elevate IOP unilaterally in two groups of rats: (1) otherwise untreated and (2) radiation pretreated, n > 25/group. Intraocular pressure histories were collected for 5 weeks, when optic nerves were prepared and graded for injury. Statistical analyses were used to compare IOP history and nerve injury. The density of microglia and macrophages in two nerve head regions was determined by Iba1 immunolabeling. RESULTS: Mean and peak IOP elevations were not different between the two glaucoma model groups. Mean optic nerve injury grades were not different in glaucoma model optic nerves and were equivalent to approximately 35% of axons degenerating. Nerves selected for lower mean or peak IOP elevations did not differ in optic nerve injury. Similarly, nerves selected for lower injury grade did not differ in IOP exposure. By multiple regression modeling, nerve injury grade was most significantly associated with mean IOP (P < 0.002). There was no significant effect of radiation treatment. Iba1+ cell density was not altered by radiation treatment. CONCLUSIONS: In contrast to previous observations in a mouse genetic glaucoma model, head-only irradiation offers the adult rat optic nerve no protection from optic nerve degeneration due to chronic, experimentally induced IOP elevation. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Michael G Anderson; Richard S Smith; Norman L Hawes; Adriana Zabaleta; Bo Chang; Janey L Wiggs; Simon W M John Journal: Nat Genet Date: 2001-12-17 Impact factor: 38.330
Authors: Hana Levkovitch-Verbin; Harry A Quigley; Keith R G Martin; Danielle Valenta; Lisa A Baumrind; Mary Ellen Pease Journal: Invest Ophthalmol Vis Sci Date: 2002-02 Impact factor: 4.799
Authors: Marta Pazos; Hongli Yang; Stuart K Gardiner; William O Cepurna; Elaine C Johnson; John C Morrison; Claude F Burgoyne Journal: Exp Eye Res Date: 2015-05-26 Impact factor: 3.467
Authors: Hongli Yang; Juan Reynaud; Howard Lockwood; Galen Williams; Christy Hardin; Luke Reyes; Cheri Stowell; Stuart K Gardiner; Claude F Burgoyne Journal: Prog Retin Eye Res Date: 2017-03-12 Impact factor: 21.198
Authors: Wesley S Bond; Jessica Hines-Beard; YPaul L GoldenMerry; Mara Davis; Alma Farooque; Rebecca M Sappington; David J Calkins; Tonia S Rex Journal: Mol Ther Date: 2015-10-27 Impact factor: 11.454
Authors: Kevin T Breen; Sarah R Anderson; Michael R Steele; David J Calkins; Alejandra Bosco; Monica L Vetter Journal: Front Neurosci Date: 2016-11-24 Impact factor: 4.677
Authors: Pete A Williams; Catherine E Braine; Nicole E Foxworth; Kelly E Cochran; Simon W M John Journal: J Neuroinflammation Date: 2017-04-26 Impact factor: 8.322
Authors: Diana C Lozano; Tiffany E Choe; William O Cepurna; John C Morrison; Elaine C Johnson Journal: Invest Ophthalmol Vis Sci Date: 2019-03-01 Impact factor: 4.799